Clinical Trial Update: Androgen Reduction in Congenital Adrenal Hyperplasia, Phase 1 [Phase 1]

View source ↗

Summary

A Phase 1 trial investigating androgen reduction in congenital adrenal hyperplasia was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Adrenal Hyperplasia

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Congenital Adrenal Hyperplasia | Phase 1 | Status: TERMINATED | Results posted: 2025-11-04